Table 4.
CLINICAL SUCCESS RATES AT 6, 12, 18, AND 24 MONTHS*
| Time (mos) | Material n (%) |
Outcome |
Total n (%) |
|
|---|---|---|---|---|
| Success n (%) |
Failure n (%) |
|||
| 6 (n=222) | DFC | 112 (98) | 2 (2) | 114 (51) |
| GMTA | 108 (100) | 0 (0) | 108 (49) | |
| FET=0.49 | ||||
| 12 (n=186) | DFC | 90 (100) | 0 (0) | 90 (48) |
| GMTA | 96 (100) | 0 (0) | 96 (52) | |
| FET† | ||||
| 18 (n=155) | DFC | 77 (99) | 1 (1) | 78 (50) |
| GMTA | 77 (100) | 0 (0) | 77 (50) | |
| FET=1.0 | ||||
| 24 (n=131) | DFC | 65 (98) | 1 (2) | 66 (50) |
| GMTA | 65 (100) | 0 (0) | 65 (50) | |
| FET=1.0 | ||||
| Combined (n=694) |
DFC | 344 (99) | 4 (1) | 348 (50) |
| GMTA | 346 (100) | 0 (0) | 346 (50) | |
| FET=0.12 | ||||
*
FET=Fisher’s exact test, 2-tailed; DFC=diluted formocresol; GMTA=gray mineral trioxide aggregate.
†
There is no difference.